Cite
Steadman D, Atkinson BN, Zhao Y, et al. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. J Med Chem. 2021;65(1):562-578doi: 10.1021/acs.jmedchem.1c01735.
Steadman, D., Atkinson, B. N., Zhao, Y., Willis, N. J., Frew, S., Monaghan, A., Patel, C., Armstrong, E., Costelloe, K., Magno, L., Bictash, M., Jones, E. Y., Fish, P. V., & Svensson, F. (2022). Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. Journal of medicinal chemistry, 65(1), 562-578. https://doi.org/10.1021/acs.jmedchem.1c01735
Steadman, David, et al. "Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity." Journal of medicinal chemistry vol. 65,1 (2022): 562-578. doi: https://doi.org/10.1021/acs.jmedchem.1c01735
Steadman D, Atkinson BN, Zhao Y, Willis NJ, Frew S, Monaghan A, Patel C, Armstrong E, Costelloe K, Magno L, Bictash M, Jones EY, Fish PV, Svensson F. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. J Med Chem. 2022 Jan 13;65(1):562-578. doi: 10.1021/acs.jmedchem.1c01735. Epub 2021 Dec 23. PMID: 34939789.
Copy
Download .nbib